Physician profile
Sheela Ananth
NPI 1285681460
$1,270.10
in general payments reported to CMS, 2019-2025
16 companies · $484 in 2025
The $484 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $38.65 · 2021: $90.02 · 2022: $56.28 · 2024: $241 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717 · Education: $7.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.24 |
| Education | $7.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $314.38 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $261.65 | 2021-2025 | Qelbree |
| Collegium Pharmaceutical, INC. | $96.07 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $94.82 | 2024 | |
| Sanofi-Aventis U.S. LLC | $88.47 | 2025 | |
| Glaxosmithkline, LLC. | $72.05 | 2019-2025 | Pediarix, Bexsero, Penmenvy |
| Kyowa Kirin, INC. | $55.75 | 2024-2025 | Crysvita |
| Sanofi Pasteur INC. | $48.04 | 2019-2024 | |
| Rhodes Pharmaceuticals L.P. | $42.29 | 2019 | |
| Adlon Therapeutics L.P. | $40.83 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $38.59 | 2019-2024 | Vaxelis, Gardasil, Gardasil 9 |
| Corium, LLC | $34.46 | 2025 | Azstarys |
| Neurelis, INC. | $29.37 | 2025 | Valtoco |
| Cranial Technologies, INC | $28.10 | 2021-2025 | Doc Band |
| Neos Therapeutics, LP | $13.73 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheela Ananth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.